Literature DB >> 17197388

Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha.

Hui Liao1, Matthew C Hyman, Daniel A Lawrence, David J Pinsky.   

Abstract

Hypoxia, as occurs during tissue ischemia, tips the natural anticoagulant/procoagulant balance of the endovascular wall to favor activation of coagulation. Plasminogen activator inhibitor-1 (PAI-1) is an important factor suppressing fibrinolysis under conditions of low oxygen tension. We previously reported that hypoxia induced PAI-1 mRNA and antigen expression in murine macrophages secondary to increased de novo transcription as well as increased mRNA stability. We now show in RAW264.7 murine macrophages that the transcription factors early growth response gene-1 (Egr-1), hypoxia-inducible factor-1alpha (HIF-1alpha), and CCAAT/enhancer binding protein alpha (C/EBPalpha) are quickly activated in hypoxia and are responsible for transcription and expression of PAI-1. Murine PAI-1 promoter constructs, including Egr, HIF-1alpha, and/or C/EBPalpha binding sites, were transfected into RAW 264.7 murine macrophages. To identify the relative importance of each of these putative hypoxia-responsive elements, cells were exposed to normobaric hypoxia, and transcriptional activity was recorded. At 16 h of hypoxic exposure, murine PAI-1 promoter deletion constructs that included Egr, HIF-1alpha, and/or C/EBPalpha binding sites demonstrated increased transcriptional activity. Mutation of each of these three murine PAI-1 promoter sites (or a combination of them) resulted in a marked reduction in hypoxia sensitivity as detected by transcriptional analysis. Functional data obtained using 32P-labeled Egr, HIF-1alpha response element (HRE), and C/EBPalpha oligonucleotides revealed induction of DNA binding activity in nuclear extracts from hypoxic RAW cells, with supershift analysis confirming activation of Egr-1, HIF-1alpha, or C/EBPalpha. ChIP analysis confirmed the authenticity of these interactions as each of these transcription factors binds to chromatin under hypoxic conditions. Further, the induction of PAI-1 by Egr-1, HIF-1alpha, or C/EBPalpha was replicated in primary peritoneal macrophages. These data suggest that although HIF-1alpha appears to dominate the PAI-1 transcriptional response in hypoxia, Egr-1 and C/EBPalpha greatly augment this response and can do so independent of HIF-1alpha or each other. These studies are relevant to ischemic up-regulation of the PAI-1 gene and consequent accrual of microvascular thrombus under ischemic conditions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17197388     DOI: 10.1096/fj.06-6285com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  49 in total

1.  Advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling and up-regulation of Egr-1 in hypoxic macrophages.

Authors:  Yunlu Xu; Fatouma Toure; Wu Qu; Lili Lin; Fei Song; Xiaoping Shen; Rosa Rosario; Joel Garcia; Ann Marie Schmidt; Shi-Fang Yan
Journal:  J Biol Chem       Date:  2010-05-27       Impact factor: 5.157

2.  cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression.

Authors:  Hui Liao; Matthew C Hyman; Amy E Baek; Keigo Fukase; David J Pinsky
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

3.  Placenta growth factor (PlGF), a novel inducer of plasminogen activator inhibitor-1 (PAI-1) in sickle cell disease (SCD).

Authors:  Nitin Patel; Nambirajan Sundaram; Mingyan Yang; Catherine Madigan; Vijay K Kalra; Punam Malik
Journal:  J Biol Chem       Date:  2010-03-29       Impact factor: 5.157

4.  Human CD4- 8- T cells are a distinctive immunoregulatory subset.

Authors:  Mei-Chuan Huang; Kalpesh Patel; Dennis D Taub; Dan L Longo; Edward J Goetzl
Journal:  FASEB J       Date:  2010-02-12       Impact factor: 5.191

5.  Loss of transcription factor early growth response gene 1 results in impaired endochondral bone repair.

Authors:  Marie K Reumann; Olga Strachna; Sarah Yagerman; Daniel Torrecilla; Jihye Kim; Stephen B Doty; Lyudmila Lukashova; Adele L Boskey; Philipp Mayer-Kuckuk
Journal:  Bone       Date:  2011-06-25       Impact factor: 4.398

6.  The heterozygote advantage of the Chuvash polycythemia VHLR200W mutation may be protection against anemia.

Authors:  Galina Y Miasnikova; Adelina I Sergueeva; Mehdi Nouraie; Xiaomei Niu; Daniel J Okhotin; Lydia A Polyakova; Tomas Ganz; Josef T Prchal; Victor R Gordeuk
Journal:  Haematologica       Date:  2011-05-23       Impact factor: 9.941

7.  Involvement of miR-30c and miR-301a in immediate induction of plasminogen activator inhibitor-1 by placental growth factor in human pulmonary endothelial cells.

Authors:  Nitin Patel; Stanley M Tahara; Punam Malik; Vijay K Kalra
Journal:  Biochem J       Date:  2011-03-15       Impact factor: 3.857

8.  Plasminogen activator inhibitor-1 (PAI-1) facilitates retinal angiogenesis in a model of oxygen-induced retinopathy.

Authors:  Anupam Basu; Gina Menicucci; Joann Maestas; Arup Das; Paul McGuire
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-05-14       Impact factor: 4.799

9.  Upstream stimulatory factor 2 and hypoxia-inducible factor 2α (HIF2α) cooperatively activate HIF2 target genes during hypoxia.

Authors:  Matthew R Pawlus; Liyi Wang; Katie Ware; Cheng-Jun Hu
Journal:  Mol Cell Biol       Date:  2012-09-10       Impact factor: 4.272

10.  Unfractionated heparin and enoxaparin reduce high-stretch ventilation augmented lung injury: a prospective, controlled animal experiment.

Authors:  Li-Fu Li; Chung-Chi Huang; Horng-Chyuan Lin; Ying-Huang Tsai; Deborah A Quinn; Shuen-Kuei Liao
Journal:  Crit Care       Date:  2009-07-06       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.